BIOLASE (NASDAQ:BIOL) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report released on Wednesday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Down 7.7 %

Shares of BIOLASE stock opened at $0.01 on Wednesday. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94. The stock has a market cap of $300,663.00, a P/E ratio of 0.00 and a beta of 0.67. The business’s 50 day moving average is $0.01 and its 200-day moving average is $0.02.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.